Inventor · disambiguated record
Benedetto Farsaci
Also filed as: FARSACI BENEDETTO
4 granted patents·4 pending applications·2 citations·filing 2017–2025
61Inventor score
Files withBRISTOL MYERS SQUIBB CO8
Top patents by PatentIndex Score
8 records- 0180US11209441B2Cytokine profiling analysisBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 28, 2021·2 cites·10 claims
- 0275US2025134996A1Treatment of hodgkin lymphoma using an anti-pd-1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0369US12222356B2Cytokine profiling analysisBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Feb 11, 2025·0 cites·12 claims
- 0466US2025155451A1Cytokine profiling analysisBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0563US2022025049A1Treatment of hodgkin lymphoma using an anti-pd-1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 0661US2022298243A1Anti-pd-1 antibody in combination with an anti-cd30 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0755US11299543B2Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatmentBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 12, 2022·0 cites·10 claims
- 0851US11083790B2Treatment of Hodgkin lymphoma using an anti-PD-1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 10, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Benedetto Farsaci files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →